Doctors, nurses and a pharmacy industry representative raise concerns about pharmacist prescribing powers, arguing that current arrangements do not provide sufficient oversight. Across the reports, healthcare professionals say the ability for pharmacists to prescribe medicines is expanding, but that monitoring and governance may not be keeping pace. They argue this could create patient safety risks, including inappropriate prescribing, inadequate checking of patient suitability, or insufficient escalation pathways when problems arise.
The outlets describe a shared call for clearer safeguards and stronger accountability measures. This includes improved oversight of how pharmacist prescribing decisions are made and reviewed, as well as ensuring appropriate standards are followed in practice. A pharmacy boss is also quoted in opposition to what is characterised as a lack of adequate governance, indicating the concerns are not limited to doctors alone.
While the coverage focuses on perceived gaps in oversight, it does not provide details of specific incidents. The common theme is that better regulation, monitoring, and support for prescribers are needed to protect patients as pharmacist prescribing roles continue to develop.
